Expert oncology group suggests not all cancer patients should be regarded as vulnerable to COVID-19

Members of the European Society for Medical Oncology say that oncologists managing patients during the COVID-19 pandemic have been urged not to delay cancer treatment that could impact on patients’ survival, as not all cancer patients should be regarded as COVID-19 vulnerable.

Pharmaceutical Journal